---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-021452"
form_type: "8-K"
ticker: "ALKS"
cik: "0001520262"
company_name: "Alkermes plc."
filed_at: "2022-05-27T23:59:59+00:00"
generated_at: "2026-06-25T06:17:28.441680+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Alkermes appoints Dr. Wright to board; two directors retire; new lead independent director

## Summary
- Christopher I. Wright, M.D., Ph.D., appointed to board effective May 24, 2022, bringing neuroscience expertise.
- David W. Anstice and Wendy L. Dixon will retire at the 2022 annual meeting; Nancy J. Wysenski named new Lead Independent Director.
- Board added seven independent directors since 2019; average tenure dropped from ~6 to ~3 years.
- Company engaged with Sarissa Capital in over 20 meetings; declined Sarissa's nominees but appointed Wright after collaboration attempts.
- Filing of preliminary proxy statement for 2022 annual meeting; board declassification and plurality voting standard approved.

## SEC filing metadata
- accession: 0001564590-22-021452
- form_type: 8-K
- ticker: ALKS
- cik: 0001520262
- company_name: Alkermes plc.
- filed_at: 2022-05-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1520262/000156459022021452/0001564590-22-021452-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1520262/000156459022021452/alks-8k_20220524.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-021452
- JSON: https://secwatch.observer/filing/0001564590-22-021452.json
- Plain text: https://secwatch.observer/filing/0001564590-22-021452.txt

## Key facts
- Executive change
  David W. Anstice AO departed as Director at Alkermes plc..
  - Action: retire
  - Role: Director
  source text: David W. Anstice AO and Wendy L. Dixon, Ph.D. notified Alkermes plc (the “Company”) of their decision to retire from the Company’s board of directors (the “Board”) and from any committees of the Board on which they serve
  evidence_url: https://www.sec.gov/Archives/edgar/data/1520262/000156459022021452/0001564590-22-021452-index.htm
- Executive change
  Christopher I. Wright was elected as Director at Alkermes plc..
  - Action: elected
  - Role: Director
  source text: the Board elected Dr. Christopher I. Wright to the Board, effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1520262/000156459022021452/0001564590-22-021452-index.htm
- Executive change
  Wendy L. Dixon departed as Director at Alkermes plc..
  - Action: retire
  - Role: Director
  source text: David W. Anstice AO and Wendy L. Dixon, Ph.D. notified Alkermes plc (the “Company”) of their decision to retire from the Company’s board of directors (the “Board”) and from any committees of the Board on which they serve
  evidence_url: https://www.sec.gov/Archives/edgar/data/1520262/000156459022021452/0001564590-22-021452-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.